Send me a link:

*Text messaging rates may apply.

 Dow Up 0.36% Nasdaq Up 0.71%

Endocyte, Inc. (ECYT)

-NasdaqGS
6.24 Up 0.19(3.14%) 3:59PM EDT
|After Hours : 6.25 Up 0.01 (0.16%) 4:43PM EDT - Nasdaq Real Time Price
Prev Close:6.05
Open:6.10
Bid:6.11 x 100
Ask:6.35 x 1000
1y Target Est:13.72
Beta:0.89
Next Earnings Date:29-Jul-14ECYT Earnings announcement
Day's Range:6.06 - 6.26
52wk Range:6.01 - 33.70
Volume:687,053
Avg Vol (3m):1,573,400
Market Cap:258.98M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ECYT

Comparison

Symbol% ChgMkt Cap
ECYTUp 3.14%258.98M
NKTRUp 0.64%1.40B
RHHBYUp 0.30%250.16B
SNSSUp 1.92%352.27M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.18
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback